Vicarious Surgical (RBOTW) Non Operating Investment Income (2021 - 2025)
Vicarious Surgical (RBOTW) reported Non Operating Investment Income of -$18000.0 for Q2 2025, down 80.0% year-over-year from -$90000.0 in Q2 2024, and up 43.75% on a QoQ basis from -$32000.0 in Q1 2025.
Vicarious Surgical (RBOTW) has 4 years of Non Operating Investment Income data on file, last reported at -$18000.0 in Q2 2025.
- Quarterly Non Operating Investment Income fell 80.0% year-over-year to -$18000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $51000.0 (down 35.44% YoY) and the FY2024 annual result came in at $40000.0, up 300.0% from the prior year.
- Non Operating Investment Income rose to -$18000.0 in Q2 2025 per RBOTW's latest filing, from -$32000.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $175000.0 in Q3 2024 and bottomed at -$195000.0 in Q2 2023.
- The 4-year median for Non Operating Investment Income is -$1513.5 (2021), against an average of $6187.0.
- Peak annual rise in Non Operating Investment Income reached 326.83% in 2024, while the deepest fall reached 178.46% in 2024.
- Tracing RBOTW's Non Operating Investment Income over 4 years: stood at $6973.0 in 2021, then surged by 1319.76% to $99000.0 in 2023, then tumbled by 174.75% to -$74000.0 in 2024, then jumped by 75.68% to -$18000.0 in 2025.
- Per Business Quant, the three latest RBOTW Non Operating Investment Income figures stand at -$18000.0 (Q2 2025), -$32000.0 (Q1 2025), and -$74000.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -55.03 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -18,000.00 |
| Jun 30, 2025 | -18,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Mar 31, 2025 | -32,000.00 |
| Dec 31, 2024 | -74,000.00 |
| Dec 31, 2024 | -74,000.00 |
| Sep 30, 2024 | 175,000.00 |
| Sep 30, 2024 | 175,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Mar 31, 2024 | -51,000.00 |
| Mar 31, 2024 | -51,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2023 | 41,000.00 |
| Sep 30, 2023 | 41,000.00 |
| Jun 30, 2023 | -195,000.00 |
| Jun 30, 2023 | -195,000.00 |
| Mar 31, 2023 | 65,000.00 |
| Mar 31, 2023 | 65,000.00 |
| Jun 30, 2021 | 6,973.00 |
| Jun 30, 2021 | 6,973.00 |
| Mar 31, 2021 | 67,271.00 |
| Mar 31, 2021 | 67,271.00 |